.png)

A super pro-rata right lets an existing investor buy more than their proportional share in a future funding round. At the seed stage, that sounds like a minor concession. At Series B, it can be the clause that quietly blocks the lead investor you need.
The core problem: Institutional Series B leads typically need to own 15–25% of a company to justify the diligence time, board seat, and capital reserves required to lead a round. If an aggressive seed investor's super pro-rata right eats into that allocation, the lead either cannot hit their ownership target or can only hit it by expanding the round. Both outcomes create problems. This is one of the most common cap table issues that kills a Series B before the lead investor even reads your deck, and it rarely gets surfaced until allocation conversations are already underway.
Super pro-rata rights are not a standard investor protection. Standard pro-rata lets investors maintain their percentage. Super pro-rata lets them grow it. That distinction matters because growth comes at someone else's expense, and at Series B, that someone is usually the new lead.
When this right becomes a blocking problem, founders face three choices:
None of those outcomes is free. The time to address this is before outreach begins, not after a term sheet is on the table.
Pro-rata rights exist in most venture deals. According to data compiled across 2024–2025 financing surveys, pro-rata rights appear in roughly 78% of VC deals. The problem is not the right itself. The problem is the version that allows an investor to increase, not just maintain, their ownership.
Here is how the three common variants compare:
Standard pro-rata is defensible. It protects an early investor from dilution without taking room from new investors. Super pro-rata is structurally different. It allows an early investor to use a future round as an opportunity to increase their stake, often at the expense of whoever is supposed to be leading that round.
The timing problem makes this worse. Most founders sign super pro-rata rights during a seed round when the company is small, the round is small, and the future Series B feels abstract. By the time a $42M median-sized Series B is on the table, that right has grown into a meaningful allocation claim. It often lives in an investor rights agreement or a side letter, not in a place founders review regularly, which means it surfaces as a surprise when allocation negotiations begin. Understanding how hidden cap table terms compound across rounds is what separates founders who go into Series B prepared from those who discover the problem mid-process.
As CRV notes in their founder guide to term sheets, super pro-rata rights can severely constrain a company's ability to bring in new investors who need substantial allocations. That constraint is the real risk.
Series B is not a casual investment. A lead investor is committing capital, taking a board seat, allocating staff time for diligence, and reserving follow-on capital for future rounds. To make that commitment work economically, most institutional leads need to own somewhere between 15% and 25% of the company post-round. Some larger funds require more.
According to GoingVC's analysis of pro-rata right dynamics, new lead investors at Series A and B commonly seek 30–50% of the round's total allocation for themselves. That is not greed. It is the minimum required to justify the economics of leading.
Now run the math on a typical deal.
In this scenario, the lead gets $8M if everyone cooperates perfectly. But if the seed investor exercises their super pro-rata right in full, the lead either gets crowded down below their threshold or the round needs to expand. A $20M round that needs to grow to $25M to satisfy everyone is a more dilutive round for the founders. It also sends a signal to the market that insider dynamics are complicated.
The real reason leads walk is not the math alone. It is the signal. When a seed investor's follow-on rights leave a lead investor fighting for their own allocation in a round they are supposed to be leading, many institutional funds simply move on. The March 2026 US venture capital market recorded $3.92 billion across 45 Series B deals, with a median deal size of $42M. There is no shortage of other companies to lead. A cap table that requires negotiation before a term sheet is even issued is a cap table that loses leads to cleaner deals.
Most founders who granted super pro-rata rights did not do so recklessly. They did so without modeling what those rights would mean three years later in a different kind of round. Here are the four mistakes that show up most often.
1. They modeled only the current round. At seed, the round is small and the right feels proportionally small. A seed investor with a super pro-rata right to claim 10% of the next round sounds manageable when the next round is hypothetical. When the next round is a $40M Series B, that 10% claim is $4M of allocation that the lead investor cannot have.
2. They granted rights without a major-investor threshold.
"Founders often agree to pro-rata rights without thresholds, leading to 20+ small claims blocking space for leads." — Expert analysis, GoingVC
Rights granted to every investor in a seed round, regardless of check size, create a long list of small claims that collectively crowd out a new lead. Lighter Capital recommends limiting pro-rata rights to investors who wrote checks above $250,000 and building a major-investor threshold into the investor rights agreement from the start.
3. They did not add a sunset date or round limit. A right that applies to every future round is structurally different from a right that applies to the next round only. Most founders do not negotiate for expiration. The result is a right that survives Series A, Series B, and beyond, growing in dollar impact with every round.
4. They overlooked side letters. Custom side letters granted to individual investors sometimes contain pro-rata language that is more aggressive than the standard investor rights agreement. These letters do not always surface in a basic cap table review. They require a full document audit to find, and they can contain language that is harder to waive than standard IRA provisions.
Understanding how these mistakes compound is part of what a full cap table review for a Series B is designed to uncover before outreach starts.
The cleanup window is before you approach investors, not after a lead expresses interest. Once a term sheet is in play, asking a seed investor to waive their rights becomes a negotiation with real leverage on the other side. Done earlier, it is a quieter conversation framed around shared interest in a successful round. The same cap table forensics process that founders use when preparing for raising a Series A round applies here: reverse-engineer your equity structure, model worst-case take-up, and find the problems before investors do.
Here is a practical pre-Series B cleanup sequence to work through with your legal counsel:
For founders navigating Series A investor rights that carry forward into a Series B, the same logic applies. The article Your Series A Investors Have Rights That Block the Series B Lead You Want covers the related governance and consent-right issues that often travel alongside pro-rata provisions.
The goal is a clean allocation story. When a lead investor asks who else is participating and what they are entitled to, the answer should be simple, documented, and already resolved.
Standard pro-rata rights let an investor maintain their current ownership percentage by buying a proportional share of a new round. Super pro-rata rights go further, allowing the investor to purchase more than their proportional share, which increases their ownership stake. That difference is what creates crowding risk at Series B, because the extra allocation comes directly from the space available to new investors.
Most institutional Series B leads target 15–25% post-round ownership to justify the economics of leading. Funds that require a board seat and maintain reserves for follow-on rounds are often at the higher end of that range. If insider participation rights reduce available allocation below that threshold, many leads will pass rather than negotiate for their own space in a round they are supposed to anchor.
No. Super pro-rata rights are contractual and cannot be unilaterally revoked. Waivers require the investor's written consent. However, waivers are frequently negotiated when the investor understands that a failed Series B hurts their own position. The leverage founders have is the shared interest in a successful institutional round. IRC Partners often identifies these provisions during a pre-raise cap table review so founders can begin waiver conversations with time to spare.
Side letters are legally binding and typically survive standard cap table software reviews. A seed investor's side letter may grant pro-rata rights that are broader than the investor rights agreement, and those rights may not be visible to a Series B lead's diligence team until late in the process. Founders should conduct a full document audit, not just a cap table export, before starting any Series B outreach.
A major-investor threshold is a minimum ownership or investment level, often 1–2% ownership or a $250,000+ check size, that an investor must meet to qualify for pro-rata rights. Setting this threshold at the seed stage prevents a long list of small investors from accumulating follow-on claims that collectively crowd out a new lead. Founders who did not set this threshold at seed should check whether any investors have fallen below the threshold due to dilution from subsequent rounds, which may have extinguished their rights automatically.
Expanding the round creates room for the lead but increases dilution for everyone, including the founders. It also signals to the market that insider dynamics are complicated, which can reduce the quality of incoming term sheets. Expansion is a last resort, not a solution. The cleaner path is resolving the rights before the round opens.
It is not too late until a term sheet is signed and the round is closing. However, the earlier founders address this, the more negotiating flexibility they have. Attempting to renegotiate pro-rata rights after a lead investor has expressed interest puts the seed investor in a position of maximum leverage. That seed round term looked fine at the time, but it can cost founders millions at Series B if it is not addressed before the process starts. Founders preparing for a Series B should build at least 60–90 days into their timeline for rights cleanup, investor communication, and document amendments before the first institutional outreach.
Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call. IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.